Neville Hall

Dr. Neville Hall is an Associate Professor of Life Sciences at Middlesex University London, affiliated with the Faculty of Natural Sciences and the Department of Life Sciences. His research focuses on oncology, specifically clinical trials and systematic reviews evaluating treatment regimens for recurrent epithelial ovarian cancer. He has collaborated on studies involving taxane monotherapy, contributing to Cochrane Database publications in 2018 and 2022.

His work emphasizes evidence-based approaches to cancer treatment, particularly in optimizing therapeutic strategies for recurrent conditions. No scientific awards are listed, though his contributions to medical oncology research are notable. Advising and grants details are not explicitly provided in the available text. Dr. Hall’s research aligns with broader themes in pharmacotherapy and clinical oncology research.